RareCan’s NHS ethics approved BioResource enables us to collect, process, analyse and store our members tumour and blood samples.
We are not creating a ‘bio bank’, building up a big resource of stored samples. Rather we are focussed on providing tailored solutions to support our clients in both preclinical programmes (e.g. identification and validation of novel drug targets or biomarkers) and clinical programmes (e.g. screening for specific target mutations).
Empower Every Patient: Become a sponsor of our clinical trial matching service
Samples we work with
- Tissue microarrays
(Where histological diagnosis precedes surgical resection)
Derived materials and data available
Digital images of H&E stained sections
DNA sequencing data
Matched clinical data
Diagnosis & comorbidities
Longitudinal treatment & symptom data
Patient reported outcome measures (PROMS)
We collaborate with partners across the healthcare system to support patients with rare cancers.